Open AccessA clinical case of effective treatment of giant prolactinoma in patient with morbid obesity
Author(s) -
Svetlana Vorotnikova,
Larisa Dzeranova,
Е А Пигарова,
Н. В. Маркина
Publication year - 2014
Publication title -
ožirenie i metabolizm
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.154
H-Index - 5
eISSN - 2306-5524
pISSN - 2071-8713
DOI - 10.14341/omet2014235-39
Subject(s) - cabergoline , prolactinoma , medicine , obesity , morbid obesity , prolactin , pediatrics , weight loss , hormone
Numerous studies showed an association between prolactin levels and body weight, with increased prevalence of obesity in patients with prolactinomas. Recent data indicate potential positive influence of cabergoline treatment to metabolic disorders in these patients. This clinical case demonstrates of a man with morbid obesity and giant prolactinoma which was successfully treated by high-dose cabergoline.